Russia, Russia, Russia! That’s all someone has talked about in the last week … and for good reason.
Unless you live under this rock (and it must be one big Rock) You already know that Russia has invaded Ukraine.
This is a tragic situation that has arisen in the lives of innocent people in an as yet unknown number and threatens investors’ money by putting the world economy at a dead end.
However, it is not all doom and gloom for investors. Even in the fog of war, there are still stocks worth considering.
One of our Green Zone Fortunes stocks from last week recorded a strong earnings year last year and has the potential to provide stable returns this year.
The pharmaceutical company Innoviva is the stock we are pumped into this week.
Innoviva, Inc. Engaged in the development, commercialization and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, a once-daily combination drug consisting of a long-acting beta-2 agonist, vilentrol, and inhaled corticosteroid, fluticasone furoat, and anuro elliptic, a single-day drug that combines a long-acting muscarinic antagonist. , umeclidinium bromide.
(Sorry for the medical jargon, I’m just the messenger!)
Last year was a year of gangbuster for Innoviva.
Who are you going to call?
Last year, Innoviva soared to new heights with these revenues and net profit which was 16.5% higher than the previous year.
Oh, and if you take the time to compare the revenue of 2021 to the revenue of 2019 (and who does not?), You will find that revenue was 50% higher.
I mean, it might be misleading because of all this epidemic thing that happened after 2019, but don’t let the facts get in the way of a good story. That’s what I always say!
Oh, and Inubia wins medical stocks overall. Innoviva shares rose 11.1% compared to 11.9% in medical stocks.
So, one score for Innoviva!
Most importantly, our green area rating is “Strong Bull” at Innoviva.
This means that we expect this stock to triple over the next 12 months.
If you would like our top list of our top Green Zone Fortunes to be sent directly to your email, Click here! יou your veteran works will be better for it!
And if you really like medical stocks and biotechnology stocks like Innoviva, can I offer another stock?
There was a new breakthrough in biotechnology … and I’m not exaggerating when I tell you it’s life changing.
This technology has the potential to cure genetic diseases such as cancer, Alzheimer’s, hepatitis, vision loss and more.
I do not know about you, but I had loved ones who suffered from some of these diseases, and I would do anything to prevent them from suffering.
Well, in the future, these concerns may become a thing of the past as soon as this biotechnological innovation explodes.
And the icing on the cake is that even when life is saved, profits will also be made … big profits!
This biotechnology technology is growing 5 times faster than internet stocks in the 90s … or, in other words, a growth of almost 200,000% in just four years!
You read that right! 200,000% in four years!
However, anyone who has a calendar knows that four years is not that much time, and time is running out to invest in this technology before everyone catches up and raises the share price of this innovative company.
So, do you want to be setting trends by buying this stock before it would be cool to do so?
Of course you are!
Therefore worthwhile Click here And let our chief investment strategist, Adam Odell, tell you about this technology he called “Empire.”
have a nice time!
Even During War, There Are Buying Opportunities Like THIS Medical Stock Source link Even During War, There Are Buying Opportunities Like THIS Medical Stock